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Changes in QTc Interval Induced With Renografin-76 and Hypaque-76
During Coronary Arteriography
GERALD L. WOLF, PhD, MD, JOHN W. HIRSHFELD, Jr., MD, FACC
Philadelphia, Pennyslvania
Renografin-76 and Hypaque-76 are both recommended
for coronary arteriography. Both have the same osmo-
lality and iodine concentration, but differ in their cal-
cium binding properties. After selective right or left
coronary arteriography in patients, Renografin-76 caused
significantly more prolongation of the QTc interval than
Radiographic contrast agents disturb contraction, metabo-
lism and electrophysiology of the heart (1-17). Animal stud-
ies (18-25) have documented a prolongation of QT interval
and a reduction of fibrillation threshold immediately after
coronary arteriography. The chemical formulation of the
contrast agent, including the radiopaque molecule (18,23,24),
the added cations (20,24) and the amount of calcium che-
lation (21,25), all influence the fibrillatory propensity of
these agents in experimental animals. Even meglumine-so-
dium diatrizoate formulations with virtually identical os-
molality and diatrizoate concentrations differ in their ar-
rhythmogenic potential in normal and ischemic animal hearts
when their calcium-binding additives are varied (21,25).
Despite a large data base suggesting that normal ionic cal-
cium is required for optimal cardiac contraction and con-
duction, commercial formulations available for coronary
arteriography differ significantly in their calcium chelating
properties. It has not been shown that these differences in
calcium binding induce significant differences in cardiac
electrophysiology in human patients.
The purpose of this investigation was to compare two
such commercial formulations, Renografin-76 (Squibb &
Sons, Inc.) and Hypaque-76 (Winthrop Laboratories), to
determine their relative adverse effects on the rate of cardiac
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did Hypaque-76. Less calcium binding in the Hypaque
formulation is probably responsible for its lesser effect
on the QTc interval. This study suggests, but does not
prove, that Hypaque-76 is safer than Renografin-76 for
coronary arteriography.
repolarization. The QTc interval was our variable of interest
because a prolonged QT interval is a risk factor for arrhyth-
mias (26-40) and sensitive to changes in blood calcium
(41,42).
Methods
Coronary arteriography. Studies were performed on
four patients undergoing selective coronary arteriography
by the Judkins technique. Selective coronary arteriography
was performed after left ventriculography. Both coronary
arteries were hand injected with both Renografin-76 and
Hypaque-76. The sequence of injections was randomized,
but each patient received at least two injections of each
agent into the left coronary artery and at least one injection
of each agent into the right coronary artery. The volume of
contrast agent delivered during each injection was recorded.
There was no difference in the volume injected between the
two groups.
QT interval measurement. Heart rate was controlled
by right atrial pacing at a rate 10 beats/min above the pa-
tient's spontaneous heart rate. Electrocardiographic leads I,
aVF and V I were recorded simultaneously using standard
electrocardiographic filters at a sensitivity of 0.5 mV/cm
and a paper speed of 50 mm/s. Recordings were begun 10
seconds before the injection and continued until the maximal
electrocardiographic changes had passed (typically 30 to 45
seconds). The QT interval was measured from the earliest
deflection of the QRS complex in any lead to the latest
completion of the T wave in any lead. Because different
patients had different cardiac cycle lengths, all QT intervals
were normalized using the Bazett correction (QT/[R - R]2).
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We report the response measured during a total of 26 in-
jections (17 left and 9 right coronary .artery studies).
Statistics. Significance of the difference between the QTc
prolongation after the Renografin-76 and the Hypaque-76
injections was tested using Student' s t test for grouped data.
Results
In these paced patients, both Renografin-76 and Hy-
paque-76 significantly prolonged the QTc interval (Table
1). In a particular patient, the degree of prolongation was
influenced by the coronary anatomy and pathology. How-
ever, in every patient, Renografi n-76 increased the QTc
interval more than a similar injection with Hypaque-76.
Each agent caused a similar temporal change, with maximal
effects at 8 to 12 seconds after injection and maximal du-
ration of less than 45 seconds. Despite the prolonged QT
intervals, no patient experienced any significantarrhythmia
during the study.
Discussion
Interest in the cardiac effects of contrast agents is exten-
sive, and Fischer and Thomson (17) have published an ex-
cellent review. The effects of ionic agents, such as diatri-
zoates, on the heart as a pump have been well characterized.
The negative inotropic effects are significantly related to
calcium-binding properties of the formulation (7,43-47).
Effect of contrast agents on fibrillation thresho ld and
QT interval. The electrophysiologic effects of contrast agents
have not been as easily studied. Although electrocardio-
graphic changes are well known, only one study (49)
has been reported utilizing direct measures of Purkinje cell
action potential and conduction velocity. In animals, the
fibrillatory potential of these agents is readily demonstrated
(20-25). At lower doses. these agents induced changes in
QT intervals (18,19). The changes in ventricular fibrillation
threshold and in QT interval are consistent within reported
animal studies and also parallel clinical experience in con-
firming the relative safety of mixed meglumine-sodium ver-
sus pure sodium or pure meglumine formulations (7,49-
52). Because direct measures of fibrillation threshold during
angiography in patients are not justified, clinical compari-
sons of commercial formulations must be inferred. We have
utilized changes in QTc interval for this inference. Prolon-
gation of the QT interval is a well known risk factor for
ventricular tachycardia or fibri llation, whether due to a con-
genital condition (26-32), electrolyte imbalance (18,19,4 1)
or the various actions of other drugs (33-40).
These two formulations differ in their sodium content as
well as the amount of calcium-binding additives (Table 2).
The diatrizoate anion also binds calcium (53,54), but is
present in the same concentration in each agent. The addition
of calcium to Renografin-76 decreases its adverse electro-
physiologiceffect (20,21); however, excess calcium begins
to enhance fibrillatory potential (24).
Clinical implications. The incidence of ventricular fi-
brillation during coronary arteriography is normally less
than 0.75% in experienced hands (55) but appears to be
appreciably higher in patients with acute myocardial in-
farction (56). Clearly, a randomized trial to prove that less
ventricular fibrillation occurs with a formulation that che-
lates less calcium would be extremely expensive because
of the requisite sample size. Because the formulations clearly
T able l. Corrected QT Inte rv a ls (ms) in Four Patients
Case: Coronary
QT : Left Coronary Angiograms QT : Right Coronary Angiograms
Angrographic Find ings Control R76 Control H76 Control R76 Control H76
I : right dominant , 397 55 1 474 487 436 55 1 435 513
LAD norm al , LCx 100%, 436 577 436 487 436 500
RCA normal 448 487
2. n ght dom inant . 413 643 430 5 17 448 5 17 47 1 5 17
LAD 90 % . LCx 90 %, 47 1 667 459 494
RCA 75%
3: right dom inant . 540 670 542 595 542 680 553 553
LAD 100%, LCx normal, 574 702 553 574
RCA normal
4: right dom inant , 450 560 428 494 46 1 659 494 582
LAD 70%. LCx normal , 472 659 461 494
RC A 50 % 483 659
Mean 470 629 470 5 14 477 60 1 473 533
± SD ± 18.9 ± 18.9 ± 15 4 ± 13.7 :!: 225 ± 40 ± 23 ± 15
R76 vs H76, p < 0 .001 R76 vs H76, P < 0.025
1176 = Hypaque-76: LAD = left anten or descending coronary artery : LCx left circumflex coronary artery : p = probability: RCA nght
coronary artery: R76 = Renografin-Zo; SD = standard deviation
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